Speaker Profile
CEO, Tolka AI Tx
Biography
Johan is the CEO and Cofounder of Tolka AI, a company making personalized medicine for hard-to-treat infections. Trained as an engineer, he worked for many years at Google, where his work included commercializing early LLM technology in 2019, which landed over 500 million dollars of contracts. Founded Tolka in 2022 to solve the $1T dollar problem of hard-to-treat infections.
Talk
AI-Powered Platform For Personalized Phage Therapy
Phage therapy is supported by decades of clinical experience but has never achieved commercial scale due to the constraints of personalization. Tolka industrializes individualized treatment by automating laboratory workflows, replacing manual documentation with agentic AI, and deploying predictive models to inform selection and manufacturing.
AI for Emerging Therapeutics Showcase:
Tolka AI Therapeutics
Tolka AI builds a personalized medicine platform for hard-to-treat infections. We are backed by Khosla Ventures.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 AI for Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies to explore the transformative role of artificial intelligence in accelerating the discovery, development, and optimization of novel therapeutic modalities. From predictive algorithms for drug efficacy to real-time analysis in clinical trials, AI is revolutionizing the way we approach emerging therapies, including RNA-based treatments, gene editing, and personalized medicine. Industry leaders and experts will discuss AI-driven advancements, collaborative frameworks, and the challenges of integrating cutting-edge technologies into therapeutic innovation. Join us for an in-depth look at how AI is shaping the future of breakthrough therapeutics.
